Erfan Taherifard
Postdoctoral AssociateAbout
Research
Publications
2026
US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance: A Review.
Taherifard E, Ross JS, Ramachandran R, Wallach JD. US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance: A Review. JAMA Health Forum 2026, 7: e260754. PMID: 41996104, DOI: 10.1001/jamahealthforum.2026.0754.Peer-Reviewed Original Research
2025
Solid Tumor Incidence and Patterns in Individuals With Down Syndrome: A Systematic Review and Meta-Analysis.
Taherifard E, Taherifard E, Bouffet E, Satgé D, Abdelbaki MS. Solid Tumor Incidence and Patterns in Individuals With Down Syndrome: A Systematic Review and Meta-Analysis. Pediatr Blood Cancer 2025, 72: e31775. PMID: 40358422, DOI: 10.1002/pbc.31775.Peer-Reviewed Original ResearchCharacteristics of patients with disseminated Bacillus Calmette-Guérin infection: a retrospective study at Namazi Hospital, Southern Iran, from 1991 to 2022.
Sanaei Dashti A, Soflaee Shahrbabak S, Malekzadeh Y, Davarpanah A, Taherifard E, Ahmadkhani A, Pouladfar G, Hamzavi SS, Kadivar MR, Geramizadeh B, Anbardar MH, Shoja K, Taherifard E. Characteristics of patients with disseminated Bacillus Calmette-Guérin infection: a retrospective study at Namazi Hospital, Southern Iran, from 1991 to 2022. J Trop Pediatr 2025, 71 PMID: 40499196, DOI: 10.1093/tropej/fmaf023.Peer-Reviewed Original ResearchAssociation of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort.
Akbari M, Poustchi H, Taherifard E, Mehrian SRA, Rahimian Z, Mesgarpour B, Pourfarzi F, Gharekhani A, Nejatizadeh A, Moradpour F, Piraie E, Fakhraei B, Joukar F, Saki N, Safarpour AR, Moradinazar M, Rezaianzadeh A, Tafaghodi M, Esmaeili-Nadimi A, Moslem A, Alijanvand MH, Moosazadeh M, Mehrparvar AH, Ansari-Moghaddam A, Taherifard E, Ghahramani S, Pakroo M, Mohammadi Z, Malekzadeh R, Vardanjani HM. Association of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort. BMC Public Health 2025, 25: 1842. PMID: 40389946, DOI: 10.1186/s12889-025-23062-y.Peer-Reviewed Original ResearchThe Effect of Zataria multiflora on Clinical, Pulmonary Function, and Oxidant Factors in Patients With Pulmonary Diseases: A Meta-Analysis of Clinical Trials.
Aali A, Taherifard E, Farshidianfar M, Hadianfard F, Alamdari F, Keshavarzian O, Nimrouzi M, Heydari ST, Akbari M. The Effect of Zataria multiflora on Clinical, Pulmonary Function, and Oxidant Factors in Patients With Pulmonary Diseases: A Meta-Analysis of Clinical Trials. Health Sci Rep 2025, 8: e70772. PMID: 40330764, DOI: 10.1002/hsr2.70772.Peer-Reviewed Original ResearchFactors Associated With Electrocardiographic Abnormalities in Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis.
Zare P, Ahmadkhani A, Taherifard E, Apelian S, Behjoo H, Taherifard E. Factors Associated With Electrocardiographic Abnormalities in Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis. Pediatr Blood Cancer 2025, 72: e31585. PMID: 39950513, DOI: 10.1002/pbc.31585.Peer-Reviewed Original ResearchESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non-Hodgkin's Lymphoma.
Dehghani M, Vojdani R, Khalafi-Nezhad A, Ravanbod MR, Ramzi M, Dehdashti S, Taherifard E, Namdari N. ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non-Hodgkin's Lymphoma. Int J Hematol Oncol Stem Cell Res 2025, 19: 151-157. PMID: 40852693, DOI: 10.18502/ijhoscr.v19i2.18552.Peer-Reviewed Original Research
2024
Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review.
Taherifard E, Tran K, Saeed A, Yasin JA, Saeed A. Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review. Diagnostics (Basel) 2024, 14 PMID: 39335733, DOI: 10.3390/diagnostics14182054.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran.
Amini A, Taherifard E, Akbari M, Taherifard E, Dehdari Ebrahimi N, Rajabi MR, Zamani F, Rekabpour SJ, Jafaraghaie R, Hassanzadeh J, Molavi Vardanjani H. The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran. Expert Rev Hematol 2024, 17: 643-650. PMID: 39061121, DOI: 10.1080/17474086.2024.2385482.Peer-Reviewed Original ResearchNeoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer.
Taherifard E, Saeed A. Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2024, 9: 59. PMID: 39503035, DOI: 10.21037/tgh-24-44.Commentaries, Editorials and Letters